Last Price$175.61.0%
Market Cap$411.8B
0.5%
Peers median - 2.3%
19.8%
Peers median - 11.1%
67.4%
Peers median - 116.1%
19.2%
Peers median - 22.0%
Competing with PG
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$411.8B | 7.1 | $135.9 22.6% overvalued | 12.1% | $84.3B | $16.7B | 0.5% | 19.8% | 51.3% | 19.2% | 67.4% | |
$143.6B | 7.0 | $90.7 57.2% undervalued | 20.3% | €120.4B | €15.8B | 7.0% | 13.1% | 71.4% | 31.3% | 142.1% | |
$75.3B | 7.0 | $83.3 10.2% overvalued | 8.6% | $20.1B | $3,546.0M | 3.3% | 17.6% | 60.5% | 30.9% | 1,564.7% | |
$47.9B | 6.4 | $160.0 11.6% undervalued | 20.3% | $20.1B | $2,513.0M | (1.8%) | 12.5% | 35.8% | 28.9% | 705.1% | |
$45.5B | 5.8 | $21.1 11.3% overvalued | 29.2% | $15.5B | $1,335.0M | 0.1% | 8.6% | 57.9% | 10.1% | 90.2% | |
$27.1B | 6.3 | $79.8 28.8% overvalued | 11.9% | $6,107.1M | $976.4M | 4.1% | 16.0% | 45.2% | 8.9% | 41.1% | |
$25.7B | 5.0 | $93.6 33.4% undervalued | (51.7%) | $15.2B | $1,145.0M | 0.1% | 7.6% | 73.1% | 0.2% | 225.1% | |
$19.3B | 6.6 | $117.2 24.8% overvalued | 5.0% | $7,165.0M | $695.0M | (2.0%) | 9.7% | 44.5% | 38.2% | 2,555.4% | |
$9,261.6M | 7.3 | $22.2 45.4% overvalued | 176.7% | $1,476.5M | $198.3M | 69.3% | 13.4% | 76.6% | 55.5% | 2.4% | |
$4,901.6M | 5.1 | $15.4 182.3% undervalued | (56.1%) | $6,090.4M | $293.5M | 1.3% | 4.8% | 64.6% | 7.0% | 7.8% | |
$3,814.9M | 6.1 | $64.1 0.4% undervalued | (69.5%) | $1,302.0M | $24.6M | 46.3% | 1.9% | 71.1% | 15.2% | 39.4% |
Compare PG Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
The Procter & Gamble CompanyPG
5.2x
2.5%
3.8%
17.7%
Median Peer Set
3.1x
2.6%
(17.5%)
8.1%
Church & Dwight Co., Inc.CHD
4.6x
4.1%
(22.7%)
9.6%
Colgate-Palmolive CompanyCL
4.1x
3.3%
27.0%
14.4%
The Clorox CompanyCLX
3.1x
(4.0%)
86.0%
3.9%
Coty Inc.COTY
0.8x
10.2%
(85.0%)
1.5%
The Estée Lauder Companies Inc.EL
2.1x
(1.9%)
(61.2%)
2.5%
e.l.f. Beauty, Inc.ELF
3.1x
76.9%
99.1%
12.5%
Hims & Hers Health, Inc.HIMS
6.1x
65.5%
(65.6%)
(2.7%)
Kimberly-Clark CorporationKMB
2.7x
(1.8%)
45.5%
12.7%
Kenvue Inc.KVUE
3.4x
0.1%
(40.0%)
6.7%
Unilever PLCUL
1.3x
1.8%
(12.4%)
10.9%
Compare PG Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does The Procter & Gamble Company (PG) revenue growth compare to peers and the industry?
The Procter & Gamble Company (PG) revenue growth is 0.5%, compared to the peers' median of 2.3%.
2. How does The Procter & Gamble Company (PG) Free Cash Flow (FCF) margin compare to peers and the industry?
The Procter & Gamble Company (PG) FCF margin is 19.8%, compared to the peers' median of 11.1%.
3. How does The Procter & Gamble Company (PG) Total Debt to Equity ratio compare to peers and the industry?
The Procter & Gamble Company (PG) Total Debt to Equity ratio is 67.4%, compared to the peers' median of 116.1%.
4. How does The Procter & Gamble Company (PG) ROIC (Return on Invested Capital) compare to peers and the industry?
The Procter & Gamble Company (PG) ROIC is 19.2%, compared to the peers' median of 22.0%.